FIGURE 6.

miR‐122‐5p inhibits apoptosis of GCs via BCL9. (A) The levels mRNA of miR‐122‐5p and BCL‐9 in GCs treated with or without CTX were assessed by quantitative real‐time polymerase chain reaction (qRT‐PCR). (B) Western blots of BCL‐9 in GCs treated with or without CTX. (C) Quantification of the western blots in (B) of BCL‐9 in GCs treated with or without CTX. (D) qRT‐PCR analysis of the levels of BCL‐9 in GCs incubated with miR‐122‐5p inhibitors. (E, F) Western blot was performed to detect the expression of BCL9 in GCs after adding the miR‐122‐5p inhibitor. Data are expressed as mean ± SD